Brown Shipley & Co’s Moderna MRNA Stock Holding History

Brown Shipley & Co’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20K	Hold	104	–	–	0.01%	68
2026 Q2	$7.28K	Hold	104	–	–	﹤0.01%	74
2026 Q1	$5.28K	Hold	104	–	–	﹤0.01%	77
2025 Q4	$3.07K	Hold	104	–	–	﹤0.01%	69
2025 Q3	$2.69K	Hold	104	–	–	﹤0.01%	62
2025 Q2	$2.87K	Hold	104	–	–	﹤0.01%	65
2025 Q1	$2.95K	Hold	104	–	–	﹤0.01%	62
2024 Q4	$4.32K	Buy	+104	New	+$4.97K	﹤0.01%	64
2024 Q1	–	Sell	-95	Closed	-$9.45K	–	104
2023 Q4	$9.45K	Hold	95	–	–	﹤0.01%	87
2023 Q3	$9.81K	Buy	+95	New	+$10.6K	0.01%	87

Other funds holding MRNA

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

BVL

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return

PFM

Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

GCA

Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return

NIM

Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return

BSCCG

Blue Sky Capital Consultants Group Poway, California $239M AUM 14.34% 1-Year Est. Return

Brown Shipley & Co's MRNA Position: Q3 2026 in Review

Brown Shipley & Co held its Moderna (MRNA) position steady in Q3 2026 at 104 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #68.

Brown Shipley & Co first reported a position in MRNA in Q3 2023 and has held it in 10 quarters since. 93 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Brown Shipley & Co held 104 shares of Moderna worth $20K as of Q3 2026.
Brown Shipley & Co left its Moderna share count unchanged in Q3 2026.
Moderna made up 0.01% of Brown Shipley & Co's portfolio in Q3 2026, its #68 holding.
Brown Shipley & Co first reported a position in Moderna in Q3 2023 and has held it in 10 quarters since.
93 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Brown Shipley & Co's 13F filing for Q3 2026, filed 9 Oct 2026.